| [1] |
Dubal PM, Unsal AA, Chung SY, et al. Population-basedtrends in outcomes in adenoid cystic carcinoma of the oral cavity[J]. Am J Otolaryngol, 2016, 37(5): 398-406.
|
| [2] |
Fallah J, Rini BI. HIF inhibitors: status of current clinical development[J]. Curr Oncol Rep, 2019, 21(1): 1-10.
|
| [3] |
Hunter BA, Eustace A, Irlam JJ, et al. Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification ininvasive bladder cancer[J]. Br J Cancer, 2014, 111(3): 437-443.
|
| [4] |
周炳娟，孙吉瑞，赵文明，等. 乳腺癌分子亚型中HIF-1α和Glut-1表达及其与基底细胞样型乳腺癌的关系[J]. 临床与实验病理学杂志，2015，31(9)：991-995.
|
| [5] |
Schodel J, Grampp S, Maher ER, et al. Hypoxia, hypoxia-inducible transcription factors, and renal cancer[J]. Eur Urol, 2016, 69(4): 646-657.
|
| [6] |
Kambe T, Tada J, Chikuma M, et al. Embryonal carcinoma P19cells produce erythropoietin constitutively but express lactatedehydrogenase in an oxygen-dependent manner[J]. Blood, 1998, 91(4): 1185-1195.
|
| [7] |
Cockman ME, Masson N, Mole DR, et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein[J]. J Biol Chem, 2000, 275(33): 25733-25741.
|
| [8] |
Tian YM, Yeoh KK, Lee MK, et al. Differential sensitivity ofhypoxia inducible factor hydroxylation sites to hypoxia andhydroxylase inhibitors[J]. J Biol Chem, 2011, 286(15): 13041-13051.
|
| [9] |
Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1[J]. Mol Cell Biol, 1996, 16(9): 4604-4613.
|
| [10] |
Fan C, Tu C, Qi P, et al. GPC6 promotes cell proliferation, migration, and invasion in nasopharyngeal carcinoma[J]. J Cancer, 2019, 10(17): 3926-3932.
|
| [11] |
Chiche J, Brahimi-Horn MC, Pouysségur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer[J]. J Cell Mol Med, 2010, 14(4): 771-794.
|
| [12] |
柳睿，马建民. 泪腺腺样囊性癌相关分子机制的研究进展[J/CD]. 中华眼科医学杂志(电子版)，2020，10(3)：177-182.
|
| [13] |
姜继宗. 氧感知机制的揭示有助于多种疾病的治疗——解读2019年诺贝尔生理学或医学奖[J]. 自然杂志，2019，41(6)：401-406.
|
| [14] |
袁扬，赵凯，卢娜. VEGF/VEGFR信号通路及其相关抑制剂研究进展[J]. 世界最新医学信息文摘(电子版)，2017，17(26)：74-75.
|
| [15] |
陈东，冯林森，王羽丰. VEGF/VEGFR2信号通路调控机制的研究进展[J]. 癌症进展，2019，17(7)：748-751.
|
| [16] |
刘佳，张美琴，于明岳，等. 唾液腺腺样囊性癌侵袭转移的研究进展[J]．中国实验诊断学，2019，23(11)：2040-2043.
|
| [17] |
孙凤琳，王晓峰. VEGF及其相关调节因子促涎腺腺样囊性癌侵袭转移的研究进展[J]. 口腔医学研究，2014，30(4)：371-374.
|
| [18] |
黄燕婷，劳均平. 沉默VEGF基因对腺样囊性癌细胞侵袭的影响[J]. 中国医学创新，2014，11(12)：37-38.
|
| [19] |
于涛，张斌，孙长伏，等. 涎腺腺样囊性癌组织中HIF-1α、VEGF、MVD的表达变化及意义[J]. 山东医药，2009，49(42)：44-45.
|
| [20] |
鲍合刚，肖亮，孟刚，等. 涎腺腺样囊性癌中HIF-1α和BCL-2的表达及意义[J]. 临床与实验病理学杂志，2017，33(7)：728-731.
|
| [21] |
孙巧妹，林宇静. HIF-1α在唾液腺腺样囊性癌中的表达及临床意义[J]. 中外医学研究，2015，13(3)：7-8.
|
| [22] |
梁军，黄志权，游云华，等. HIF-1α和VEGF的表达与腺样囊性癌临床病理的相关性研究[J]. 中国口腔颌面外科杂志，2010，8(6)：548-554.
|
| [23] |
刘海涛. MMP-7和VEGF-A在腭部涎腺腺样囊性癌中的表达及意义[D]. 南昌：南昌大学，2016.
|
| [24] |
汪佳，安峰，申叶春，等. Id-1和VEGF在涎腺腺样囊性癌中的表达及临床意义[J]. 现代中西医结合杂志，2016，25(21)：2286-2292.
|
| [25] |
王璐. 联合检测血清E-cad、MMP-2及VEGF的表达对涎腺腺样囊性癌的诊断价值[J]. 贵州医科大学学报，2017，42(2)：241-244.
|
| [26] |
马赛，安峰，胥爱文，等. CEACAM-1和VEGF在涎腺腺样囊性癌中的表达及临床意义[J]. 山西医学大学学报，2016，47(11)：1022-1025.
|
| [27] |
李晓光，于肖鹏，卢会青，等. VEGF表达在涎腺腺样囊性癌中的意义[J]. 口腔医学研究，2011，27(6)：501-503.
|
| [28] |
Wang HF, Wang SS, Zheng M, et al. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma[J]. Cell Prolif, 2019, 52(3): e12600.
|
| [29] |
肖楚. 沉默HIF-1α对人涎腺腺样囊性癌SACC-83细胞生长、侵袭及血管形成的影响[D]. 南昌：南昌大学，2017.
|
| [30] |
Liu D, Balkin ER, Jia F, et al. Targeted antisense radiotherapy and dose fractionation using a (177) Lu-labeled anti-BCL-2 peptide nucleic acid-peptide conjugate[J]. Nucl Med Biol, 2015, 42(9): 704-710.
|
| [31] |
王敬. 涎腺腺样囊性癌中MTA1、HIF-1α的表达及临床意义[D]. 武汉：华中科技大学，2013.
|
| [32] |
Chen Z, Wu H, Huang S, et al. Expression of BNIP3 and its correlations to hypoxia-induced autophagy and clinicopathological features in salivary adenoid cystic carcinoma[J]. Cancer Biomark, 2015, 15(4): 467-475.
|
| [33] |
Chen Z, Sun D, Huang S, et al. Analysis of BNIP3 expression and clinical research in salivary adenoid cystic carcinoma[J]. Hua Xi Kou Qiang Yi Xue Za Zhi, 2016, 34(4): 404-407.
|
| [34] |
Wu H, Huang S, Chen Z, et al. Hypoxia-induced autophagy contributes to the invasion of salivary adenoid cystic carcinoma through the HIF-1α/BNIP3 signaling pathway[J]. Mol Med Rep, 2015, 12(5): 6467-6474.
|
| [35] |
Wang YF, Ma SR, Wang WM, et al. Inhibition of survivin reduces HIF-1α，TGF-β1 and TFE3 in salivary adenoid cystic carcinoma[J]. PLoS One, 2014, 9(12): e114051.
|
| [36] |
Stenner M, Demgensky A, Molls C, et al. Prognostic value of survivin expression in parotid gland cancer in consideration of different histological subtypes[J]. Eur J Cancer, 2011, 47(7): 1013-1020.
|
| [37] |
Mulay K, Puthyapurayil FM, Mohammad JA, et al. Adenoid cysticcarcinoma of the lacrimal gland: Role of nuclear surviving (BIRC5) as a prognostic marker[J]. Histopathology, 2013, 62(6): 840-846.
|
| [38] |
Lim YS, Cha W, Park MW, et al. HIF1α in tumorigenesis of adenoid cystic carcinoma[J]. Anticancer Res, 2017, 37(2): 599-606.
|
| [39] |
鲍合刚. HIF-1α和BCL2在涎腺腺样囊性癌组织中的表达以及对细胞放射敏感性的影响[D]. 合肥：安徽医科大学，2017.
|
| [40] |
Cherifi F, Rambeau A, Johnson A, et al. Systemic treatments of metastatic or locally recurrent adenoid cystic carcinoma of the head and neck, a systematic review[J]. Bull Cancer, 2019, 106(10): 923-938.
|
| [41] |
朱栩，白忠诚，汤楚华，等. 125I对涎腺腺样囊性癌移植瘤中MMP-2和VEGF的表达影响[J]. 中华老年口腔医学杂志，2018，16(3)：147-150.
|
| [42] |
Ou Yang KX, Liang J, Yang ZN, et al. A study on the inhibition of VEGF expression in salivary gland adenoid cystic carcinoma cells via iNOS gene RNAi in vitro[J]. J Oral Pathol Med, 2015, 44(2): 153-158.
|
| [43] |
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more " personalized" approach to cancer staging[J]. CA Cancer J Clin, 2017, 67: 93-99.
|
| [44] |
Hung JY, Wei YH, Huang CH, et al. Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland[J]. Japanese Journal of Ophthalmology, 2019, 63: 344-351.
|
| [45] |
Costa AF, Tasso MG, Mariano FV, et al. Levels and patterns of expression of hypoxia-inducible factor-1α，vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation[J]. Histopathology, 2012, 60(5): 816-825.
|
| [46] |
Wang WM, Zhao ZL, Zhang WF, et al. Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma[J]. Mol Med Rep, 2015, 12(3): 3432-3438.
|
| [47] |
Park S, Nam SJ, Keam B, et al. VEGF and Ki-67 overexpression in predicting poor overall survival in adenoid cystic carcinoma[J]. Cancer Res Treat, 2016, 48(2): 518-526.
|